Title
Association between insulin resistance and c-reactive protein among Peruvian adults
Date Issued
21 June 2010
Access level
open access
Resource Type
journal article
Author(s)
Gelaye B.
Hevner K.
Fitzpatrick A.L.
Williams M.A.
Publisher(s)
Springer Nature
Abstract
Objective. Insulin resistance (IR), a reduced physiological response of peripheral tissues to the action of insulin, is one of the major causes of type 2 diabetes. We sought to evaluate the relationship between serum C-reactive protein (CRP), a marker of systemic inflammation, and prevalence of IR among Peruvian adults. Methods. This population based study of 1,525 individuals (569 men and 956 women; mean age 39 years old) was conducted among residents in Lima and Callao, Peru. Fasting plasma glucose, insulin, and CRP concentrations were measured using standard approaches. Insulin resistance was assessed using the homeostasis model (HOMA-IR). Categories of CRP were defined by the following tertiles: <0.81 mg/l, 0.81-2.53 mg/l, and >2.53 mg/l. Logistic regression procedures were employed to estimate odds ratios (OR) and 95% confidence intervals (CI). Results. Elevated CRP were significantly associated with increased mean fasting insulin and mean HOMA-IR concentrations (p < 0.001). Women with CRP concentration >2.53 mg/l (upper tertile) had a 2.18-fold increased risk of IR (OR = 2.18 95% CI 1.51-3.16) as compared with those in the lowest tertile (<0.81 mg/l). Among men, those in the upper tertile had a 2.54-fold increased risk of IR (OR = 2.54 95% CI 1.54-4.20) as compared with those in the lowest tertile. Conclusion. Our observations among Peruvians suggest that chronic systemic inflammation, as evidenced by elevated CRP, may be of etiologic importance in insulin resistance and diabetes. © 2010 Gelaye et al.
Volume
2
Issue
1
Language
English
OCDE Knowledge area
Endocrinología, Metabolismo (incluyendo diabetes, hormonas)
Scopus EID
2-s2.0-77953553852
Source
Diabetology and Metabolic Syndrome
ISSN of the container
17585996
Sponsor(s)
Funding text
This study was supported by the Direccion General de Epidemiologia Ministe-rio de Salud Peru, by an award from the National Institutes of Health, National Center on Minority Health and Health Disparities (T37-MD001449), and by the Instituto Nacional de Salud Peru.
Sources of information:
Directorio de Producción Científica
Scopus